The legalization bill would allow adults over 21 to possess up to 1 ounce (28 grams) of cannabis from January 1, 2024.
The biotech and life sciences company Mydecine Innovations Group recently announced it had completed its first commercial export of legal psychedelic psilocybin mushrooms from Jamaica to Canada. Technology Networks caught up with the company's chief scientific officer, Rob Roscow, to find out more.
Two of the new facilities, based in Oregon and Nevada, have been acquired by Kaycha. The other, based in Massachusetts, was built for the company.
Regulation is incoming for the UK's CBD industry. But are companies clued up on the new requirements? Not always, say CBD analysts, and the confusing guidance may be partly to blame.
There is little relationship between saliva limits on cannabis-impaired driving and the driver’s actual impairment, according to the findings of a new study.
The finding stands in contrast to other recent studies, which have found teen cannabis use decreases in states that have legalized adult-use cannabis.
A group of Michigan-based lab analysts say the qPCR method is unsuitable for detecting mold. Other lab analysts disagree, yet the state regulator has still temporarily banned the test.
US counties with higher numbers of legal cannabis dispensaries recorded lower levels of opioid-related deaths relative to other locales, according to a new study.
Is the current lexicon used by cannabis industry insiders appropriate? Not always, according to a new study.